Inducción a la formación profesional

Desarrolla a manera de módulos, la forma y la información que de se debe entregar a los aprendices al momento de que estos ingresen a la institución para conocer el contexto, deberes, derechos, entre otros, que los estarán rodeando en el ámbito académico.It develops as a module, the form and the information that must be given to the apprentices when they enter the institution to know the context, duties, rights, among others, that will be surrounding them in the academic field.Conocimiento e Integración Grupal -- Inducción al SENA -- Inducción a la Formación Profesional Integral -- Inducción al Centro, Programa o Proyecto -- Inducción al Programa de Formación Profesional -- Inducción a los Servicios al Alumnado -- Servicios al Alumnado: Biblioteca -- Servicios al Alumnado: Promoción y contratación de Aprendices -- Servicios al Alumnado: Trabajo Social -- Servicios al Alumnado: Capellanía -- Servicios al Alumnado: Registro y Certificación -- Servicios al Alumnado: Validación -- Servicios al Alumnado: Actividades Recreativas, Culturales y Deportivas.naPara sujetos de formación40 página

Emulsifying Properties of Dried Soy-Whey, Dried Tofu-Whey, and Their Isolated Proteins

This paper focuses on the comparative study of emulsifying properties of dried tofu-whey, dried soy-whey and their isolated proteins. Oil-in-water emulsions were prepared at equivalent protein concentration (0.1, 0.5 and 1.0 g/100 mL), using sunflower oil as lipid phase (oil mass fraction = 0.33). Tofu-whey and soy-whey were dehydrated by freeze-drying (LTW and LSW, respectively) or thermal-drying (DTW and DSW, respectively). Moreover, a heated LSW sample in anhydrous condition (h-LSW) was included. The emulsion formation and stability at rest was evaluated using a vertical scan analyzer, according to multiple light scattering theory, particle size and oiling off measurements. Even though the stability to gravitational separation and coalescence increased with increasing protein concentration, freeze-dried whey samples exhibited a higher ability to form and stabilize emulsions respect to that of thermally-dried ones, especially for those obtained from soy-whey. Moreover, h-LSW emulsions were more stable than that of LSW sample presumably due to protein glycosylation. The global emulsion stability decreased in the order: LTW>DTW>h-LSW>LSW>DSW. Moreover, at equivalent protein concentration in the continuous phase, the isolation of proteins from lyophilized whey-samples by treatment with cold acetone (LTW-P, LSW-P and h-LSW-P, respectively) improved their emulsifying properties. Again, this improvement was more pronounced for samples obtained from soy-whey, probably due to partial protein denaturation associated to treatment with the organic solvent. In conclusion, this paper should be considered as basis for further studies concerned with the potential application of soy-whey and tofu-whey proteins as emulsifiers in different systems

Aplication of animal biotechnologies for the preservation and multiplication of colombian criollo cattle

IP 2121-12-137-94v.1 Informe final. -- v.2 Application of animal biotechnologiesfor the preservation and multiplication of colombian criollo cattle (II) / Jorge Ossa, Fabio Nelson Zuluaga.-- s.l : Revista Colombiana de Ciencias Pecuarias, 1997 --p.28cm. -- ISSN 01200690 -- Obtencion de;embriones bovinos in vitro. / R. Sierra, J.A. Berdugo, M.AngelOlivera.En: Encuentro Nacional de;Investigadores de las Ciencias Pecuarias (4 : 1997 nov. 6-0,291666666666667Colombia) --[s.l] : Revista Colombiana de;Ciencias Pecuarias, 1997 -- p. 28 cm. -- ISSN 01200690 --Amplificacion desecuencias repetidas en tandem;PONENCIA(S) EN CONGRESO: Cultivo de celulas de granulosa bovina/ J.A. Berdugo, R. Sierra, Angel M. Oliveira;'-- en: Encuentro nacional de Investigadores de las ciencias Pecuarias (4 :1997 nov. 6-7 : Colombia) [s.l] :;Revista Colombiana de Ciencias Pecuarias, 1997 -- p. 28 cm. --ISSN 01200690 -- Efecto de la;superoxidodismutasa y de la tioredoxina sobre embriones bovinosproducidosin vitro / O. Camargo Rodriguez ...;[et al.] -- En: Encuentro Nacional de Investigadores de las Ciencias Pecuarias (4 : 1997 nov. 6-7 : Colombia);J.A Berdugo, J. Yunis. En: Encuentro Nacional de Investigadoresde las Ciencias Pecuarias (4 : 1997 nov. 6-7;: Colombia) -- [s.l] : Revista Colombiana de Ciencias Pecuarias,1997 -- p. 28 cm. -- ISSN 01200690 --;Caracterizacion citogenetica de la raza bon. / G. Vasquez...[et al.] --En: Encuentro Nacional de;Investigadores de las Ciencias Pecuarias (4 : 1997 nov. 6-0,291666666666667Colombia) --[s.l] : Revista Colombiana de;Ciencias Pecuarias, 1997 -- p. 28 cm. -- ISSN 01200690 --Genetic characterization of colombioan crillo;(str) en ganado cebu Brahman Bases moleculares de las pruebasdeidentificacion de individuos (paternidad). /;Supervolutary response of colombian creole cattle to two dosesof fsh / J.L. Estrada ... [et al.] En: Global;Conference on Conservation of Domestic Genetic Resources.(3 :1994 Aug. 1-5 : Ontario, Canada). -- [s.l :;s.n] ; 28 cm. -- ARTICULO(S) EN REVISTA: Effects of superoxidedismutase and thioredoxin on bovine embryo;development in vitro / J.L Estrada .. [et.al] -- En: Theriogenology. -- no.1, vol. 49 (jan. 1998); p. 280 --;ISSN: 0093-691X -- Supervolutary response of colombian creolecattle to two doses of FSH / J.L Estrada ..;[et.al] -- vol. 49, no. 1 (Jan. 1998); p. 337 -- ISSN 0093-691X.;cattle / Derr James ... [et al.] -- En: Global Conferenceon Conservationof Domestic Genetic Resources. (3 :;1994 Aug. 1-5 : Ontario, Canada). -- [s.l] : Rare Breeds International, 1995 -- p. 11 ; 28 cm. -

Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children: a propensity-weighted cohort study

BackgroundMultisystem inflammatory syndrome in children (MIS-C), a hyperinflammatory condition associated with SARS-CoV-2 infection, has emerged as a serious illness in children worldwide. Immunoglobulin or glucocorticoids, or both, are currently recommended treatments.MethodsThe Best Available Treatment Study evaluated immunomodulatory treatments for MIS-C in an international observational cohort. Analysis of the first 614 patients was previously reported. In this propensity-weighted cohort study, clinical and outcome data from children with suspected or proven MIS-C were collected onto a web-based Research Electronic Data Capture database. After excluding neonates and incomplete or duplicate records, inverse probability weighting was used to compare primary treatments with intravenous immunoglobulin, intravenous immunoglobulin plus glucocorticoids, or glucocorticoids alone, using intravenous immunoglobulin as the reference treatment. Primary outcomes were a composite of inotropic or ventilator support from the second day after treatment initiation, or death, and time to improvement on an ordinal clinical severity scale. Secondary outcomes included treatment escalation, clinical deterioration, fever, and coronary artery aneurysm occurrence and resolution. This study is registered with the ISRCTN registry, ISRCTN69546370.FindingsWe enrolled 2101 children (aged 0 months to 19 years) with clinically diagnosed MIS-C from 39 countries between June 14, 2020, and April 25, 2022, and, following exclusions, 2009 patients were included for analysis (median age 8·0 years [IQR 4·2-11·4], 1191 [59·3%] male and 818 [40·7%] female, and 825 [41·1%] White). 680 (33·8%) patients received primary treatment with intravenous immunoglobulin, 698 (34·7%) with intravenous immunoglobulin plus glucocorticoids, 487 (24·2%) with glucocorticoids alone; 59 (2·9%) patients received other combinations, including biologicals, and 85 (4·2%) patients received no immunomodulators. There were no significant differences between treatments for primary outcomes for the 1586 patients with complete baseline and outcome data that were considered for primary analysis. Adjusted odds ratios for ventilation, inotropic support, or death were 1·09 (95% CI 0·75-1·58; corrected p value=1·00) for intravenous immunoglobulin plus glucocorticoids and 0·93 (0·58-1·47; corrected p value=1·00) for glucocorticoids alone, versus intravenous immunoglobulin alone. Adjusted average hazard ratios for time to improvement were 1·04 (95% CI 0·91-1·20; corrected p value=1·00) for intravenous immunoglobulin plus glucocorticoids, and 0·84 (0·70-1·00; corrected p value=0·22) for glucocorticoids alone, versus intravenous immunoglobulin alone. Treatment escalation was less frequent for intravenous immunoglobulin plus glucocorticoids (OR 0·15 [95% CI 0·11-0·20]; p<0·0001) and glucocorticoids alone (0·68 [0·50-0·93]; p=0·014) versus intravenous immunoglobulin alone. Persistent fever (from day 2 onward) was less common with intravenous immunoglobulin plus glucocorticoids compared with either intravenous immunoglobulin alone (OR 0·50 [95% CI 0·38-0·67]; p<0·0001) or glucocorticoids alone (0·63 [0·45-0·88]; p=0·0058). Coronary artery aneurysm occurrence and resolution did not differ significantly between treatment groups.InterpretationRecovery rates, including occurrence and resolution of coronary artery aneurysms, were similar for primary treatment with intravenous immunoglobulin when compared to glucocorticoids or intravenous immunoglobulin plus glucocorticoids. Initial treatment with glucocorticoids appears to be a safe alternative to immunoglobulin or combined therapy, and might be advantageous in view of the cost and limited availability of intravenous immunoglobulin in many countries.FundingImperial College London, the European Union's Horizon 2020, Wellcome Trust, the Medical Research Foundation, UK National Institute for Health and Care Research, and National Institutes of Health